These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35142286)

  • 1. Ganglion cell maturation in peripheral neuroblastic tumours of children.
    Sarnat HB; Yu W
    Clin Neuropathol; 2022; 41(3):101-113. PubMed ID: 35142286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation of metastases in peripheral neuroblastic tumors (neuroblastoma) of children.
    Sarnat HB; Chan ES; Ng D; Yu W
    J Neuropathol Exp Neurol; 2023 Sep; 82(10):853-864. PubMed ID: 37682248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.
    Molenaar WM; Baker DL; Pleasure D; Lee VM; Trojanowski JQ
    Am J Pathol; 1990 Feb; 136(2):375-82. PubMed ID: 1689542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
    Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
    Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
    Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma.
    Hicks MJ; Mackay B
    Ultrastruct Pathol; 1995; 19(4):311-22. PubMed ID: 7571090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
    Warren M; Matsuno R; Tran H; Shimada H
    Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
    Hachitanda Y; Tsuneyoshi M; Enjoji M
    Arch Pathol Lab Med; 1989 Apr; 113(4):381-4. PubMed ID: 2495784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
    Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
    J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
    Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
    Wen Y; Peng Y; Duan XM; Zhang N
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
    Munchar MJ; Sharifah NA; Jamal R; Looi LM
    Pathology; 2003 Apr; 35(2):125-9. PubMed ID: 12745459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ret-oncogene expression correlates with neuronal differentiation of neuroblastic tumors.
    Ikuno N; Shimokawa I; Nakamura T; Ishizaka Y; Ikeda T
    Pathol Res Pract; 1995 Mar; 191(2):92-9. PubMed ID: 7567689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.
    Choi JH; Ro JY
    Semin Diagn Pathol; 2022 Mar; 39(2):120-130. PubMed ID: 34167847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
    Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
    Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
    de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
    Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.